Please call your physician’s office before coming in for your appointment if you have symptoms of a cough, fever, or difficulty breathing; traveled to Europe or China or other areas impacted by the coronavirus (COVID-19) within the past 14 days; been in close contact with someone who has traveled outside the U.S. to one of the impacted countries; or may have been exposed to the coronavirus. Effective Monday May 18th all VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Our new office hours are: Monday through Friday 8:30 a.m. to 4:00 p.m, if you have an appointment scheduled for after hours, our office will be contacting you directly to reschedule. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Physician Publications

Virginia Cancer Specialists » Protected: Chemotherapy Class » Physician Publications » Page 2

Physician Publications

October 14, 2019

Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer

Read More
October 1, 2019

A review of canakinumab and its therapeutic potential for non-small cell lung cancer.

Read More
September 25, 2019

Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype.

Read More
August 21, 2019

Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.

Read More
August 1, 2019

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

Read More
August 1, 2019

Detection of NRG1 Gene Fusions in Solid Tumors.

Read More